SAILIFE

Fundamental Analysis: Sai Life Sciences Ltd is a pharmaceutical company focused on APIs, formulations, and contract development & manufacturing (CDMO) services. In the latest quarter, revenue grew by 26.50% and profit grew by 85%. Additionaly, the institutional holdings increased by 0.40% with reasonable valuation at the P/E of 62.4x as compared to last 10 years average. Technical Analysis: The stock has recently broken out above the key resistance zone near ₹980, which had acted as a supply area earlier. Price is now trading near recent swing highs around ₹1,000–1,010, indicating strength. RSI is gradually improving while ADX remains moderate, suggesting a developing trend.